FindTrial
Sign In

Ingestion of vinegar for preventing of cancer recurrence in patients underwent esophageal endoscopic submucosal dissection: a prospective randomized controlled trial

Ingestion of vinegar for preventing of cancer recurrence in patients underwent esophageal endoscopic submucosal dissection: a prospective randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024685
Enrollment
Unknown
Registered
2019-07-21
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal cancer

Interventions

Intervention group:additional vinegar ingestion
Control group:no additional vinegar ingestion

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients who underwent esophageal endoscopic submucosal dissection.

Exclusion criteria

Exclusion criteria: 1) non-curative resection; 2) with additional treatments after esophageal endoscopic submucosal dissection (including surgery, radiotherapy, or chemotherapy); 3) complicated with severe esophageal stricture after endoscopic submucosal dissection and cannot eat; 4) with other gastrointestinal cancer or non-gastrointestinal cancer; 5) history of radiotherapy or chemotherapy for any other cancer; 6) history of gout; 7) refused to participate the study or cannot give informed consent.

Design outcomes

Primary

MeasureTime frame
esophageal cancer recurrence in 2 years;—

Secondary

MeasureTime frame
Vinegar related adverse events;—

Countries

China

Contacts

Public ContactBing Hu

West China Hospital, Sichuan University

hubingnj@163.com+86 18980601278

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026